Skip Nav Destination
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated
Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation
Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti–vascular endothelial growth factor receptor therapy
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia
Issue Archive
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
ERRATA
REVIEW ARTICLES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup
Clinical Trials & Observations
Stéphanie Nguyen,Thierry Leblanc,Pierre Fenaux,Francis Witz,Didier Blaise,Arnaud Pigneux,Xavier Thomas,Françoise Rigal-Huguet,Bruno Lioure,Anne Auvrignon,Denis Fière,Josy Reiffers,Sylvie Castaigne,Guy Leverger,Jean-Luc Harousseau,Gérard Socié,Hervé Dombret,for the French AML Intergroup including the Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM), the Leucémies Aiguës Myéloblastiques de l'Enfant (LAME), the Acute Leukemia French Association (ALFA), and the Bordeaux Grenoble Marseille Toulouse (BGMT) cooperative groups
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation
Clinical Trials & Observations
Charles G. Mullighan,Sue Heatley,Kathleen Doherty,Ferenc Szabo,Andrew Grigg,Timothy P. Hughes,Anthony P. Schwarer,Jeff Szer,Brian D. Tait,L. Bik To,Peter G. Bardy
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.
Clinical Trials & Observations
Charles L. Sawyers,Andreas Hochhaus,Eric Feldman,John M. Goldman,Carole B. Miller,Oliver G. Ottmann,Charles A. Schiffer,Moshe Talpaz,Francois Guilhot,Michael W. N. Deininger,Thomas Fischer,Steve G. O'Brien,Richard M. Stone,Carlo B. Gambacorti-Passerini,Nigel H. Russell,Jose J. Reiffers,Thomas C. Shea,Bernard Chapuis,Steven Coutre,Sante Tura,Enrica Morra,Richard A. Larson,Alan Saven,Christian Peschel,Alois Gratwohl,Franco Mandelli,Monique Ben-Am,Insa Gathmann,Renaud Capdeville,Ronald L. Paquette,Brian J. Druker
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated
Clinical Trials & Observations
Jeffrey T. Billheimer,Ira B. Dicker,Richard Wynn,Jodi D. Bradley,Debra A. Cromley,Helen E. Godonis,Lisa C. Grimminger,Bokang He,Cathy J. Kieras,Donna L. Pedicord,Susan M. Spitz,Beth E. Thomas,Nina I. Zolotarjova,Mary A. Gorko,Gregory F. Hollis,Robert N. Daly,Andrew M. Stern,Dietmar Seiffert
Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase
Clinical Trials & Observations
Hagop M. Kantarjian,Jorge Cortes,Susan O'Brien,Francis J. Giles,Maher Albitar,Mary Beth Rios,Jianqin Shan,Stefan Faderl,Guillermo Garcia-Manero,Deborah A. Thomas,Debra Resta,Moshe Talpaz
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
Clinical Trials & Observations
Michael J. Keating,Ian Flinn,Vinay Jain,Jacques-Louis Binet,Peter Hillmen,John Byrd,Maher Albitar,Lee Brettman,Pedro Santabarbara,Bret Wacker,Kanti R. Rai
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
Bruce S. Sachais,Alice Kuo,Taher Nassar,Jeanelle Morgan,Katalin Kariko,Kevin Jon Williams,Michael Feldman,Michael Aviram,Neelima Shah,Leonard Jarett,Mortimer Poncz,Douglas B. Cines,Abd Al-Roof Higazi
IMMUNOBIOLOGY
Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
Régis T. Costello,Simona Sivori,Emanuela Marcenaro,Marina Lafage-Pochitaloff,Marie-Joelle Mozziconacci,Denis Reviron,Jean-Albert Gastaut,Daniela Pende,Daniel Olive,Alessandro Moretta
Constitutive nuclear factor–κB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins
Fabrice Bureau,Alain Vanderplasschen,Fabrice Jaspar,Frédéric Minner,Paul-Pierre Pastoret,Marie-Paule Merville,Vincent Bours,Pierre Lekeux
Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy
Yasushi Ikuta,Naoyuki Katayama,Lijie Wang,Toshiharu Okugawa,Yoshiyuki Takahashi,Michael Schmitt,Xiaogang Gu,Masato Watanabe,Kazunari Akiyoshi,Hideo Nakamura,Kagemasa Kuribayashi,Junzo Sunamoto,Hiroshi Shiku
NEOPLASIA
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
Rafael Fonseca,Emily A. Blood,Martin M. Oken,Robert A. Kyle,Gordon W. Dewald,Richard J. Bailey,Scott A. Van Wier,Kimberly J. Henderson,James D. Hoyer,David Harrington,Neil E. Kay,Brian Van Ness,Philip R. Greipp
Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3
German Ott,Tiemo Katzenberger,Andreas Lohr,Steffi Kindelberger,Thomas Rüdiger,Martin Wilhelm,Jörg Kalla,Andreas Rosenwald,Justus G. Müller,M. Michaela Ott,Hans Konrad Müller-Hermelink
RED CELLS
TRANSPLANTATION
Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation
Clinical Trials & Observations
Holger Hebart,Senay Daginik,Stefan Stevanovic,Ulrich Grigoleit,Andrea Dobler,Manuela Baur,Georg Rauser,Christian Sinzger,Gerhard Jahn,Juergen Loeffler,Lothar Kanz,Hans-Georg Rammensee,Hermann Einsele
BRIEF REPORTS
Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti–vascular endothelial growth factor receptor therapy
Clinical Trials & Observations
Brief Report
Stéphane Richard,Laure Croisille,Jeannine Yvart,Nicole Casadeval,Pascal Eschwège,Nozar Aghakhani,Philippe David,Alain Gaudric,Paul Scigalla,Olivier Hermine
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia
Clinical Trials & Observations
Brief Report
Ayalew Tefferi,Ruben A. Mesa,Leigh A. Gray,David P. Steensma,John K. Camoriano,Michelle A. Elliott,Animesh Pardanani,Stephen M. Ansell,Timothy G. Call,Gerardo Colon-Otero,Georgene Schroeder,Curtis A. Hanson,Gordon W. Dewald,Scott H. Kaufmann
CORRESPONDENCE
CD antigens 2002
David Mason,Pascale André,Armand Bensussan,Chris Buckley,Curt Civin,Edward Clark,Masja de Haas,Sanna Goyert,Martin Hadam,Derek Hart,Václav Hořejšı́,Stefan Meuer,James Morrissey,Reinhard Schwartz-Albiez,Stephen Shaw,David Simmons,Mariagrazia Uguccioni,Ellen van der Schoot,Eric Vivier,Heddy Zola
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals